Temasek Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Temasek Holdings’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,372,712	Closed	-$200M	–	53
2020 Q1	$200M	Hold	2,372,712	–	–	1.48%	14
2019 Q4	$201M	Hold	2,372,712	–	–	1.31%	14
2019 Q3	$160M	Hold	2,372,712	–	–	1.17%	16
2019 Q2	$203M	Hold	2,372,712	–	–	1.45%	16
2019 Q1	$211M	Hold	2,372,712	–	–	1.46%	18
2018 Q4	$202M	Hold	2,372,712	–	–	1.39%	17
2018 Q3	$230M	Sell	2,372,712 -1,100,000	-32%	-$110M	1.34%	17
2018 Q2	$327M	Hold	3,472,712	–	–	1.72%	13
2018 Q1	$282M	Hold	3,472,712	–	–	1.54%	15
2017 Q4	$310M	Hold	3,472,712	–	–	1.9%	11
2017 Q3	$323M	Hold	3,472,712	–	–	1.88%	10
2017 Q2	$315M	Hold	3,472,712	–	–	2.03%	6
2017 Q1	$305M	Hold	3,472,712	–	–	2.27%	6
2016 Q4	$288M	Hold	3,472,712	–	–	2.3%	7
2016 Q3	$321M	Hold	3,472,712	–	–	2.6%	7
2016 Q2	$270M	Hold	3,472,712	–	–	2.11%	8
2016 Q1	$286M	Hold	3,472,712	–	–	2.26%	8
2015 Q4	$364M	Buy	3,472,712 +888,545	+34%	+$92.8M	2.76%	7
2015 Q3	$272M	Hold	2,584,167	–	–	2.58%	10
2015 Q2	$353M	Buy	2,584,167 +621,755	+32%	+$77M	2.21%	8
2015 Q1	$245M	Sell	1,962,412 -170,366	-8%	-$18.1M	1.83%	9
2014 Q4	$193M	Hold	2,132,778	–	–	2%	12
2014 Q3	$154M	Hold	2,132,778	–	–	1.64%	11
2014 Q2	$133M	Buy	2,132,778 +580,924	+37%	+$35.1M	1.99%	9
2014 Q1	$106M	Buy	+1,551,854	New	+$114M	1.64%	10

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Temasek Holdings's BMRN Position: Q2 2020 in Review

Temasek Holdings sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2020, closing a stake of 2,372,712 shares — an estimated $200M sold.

Temasek Holdings first reported a position in BMRN in Q1 2014 and held it in 25 quarters. The position peaked at $364M in Q4 2015. 527 funds tracked by Wall St. Rank hold BMRN as of Q2 2020.

Temasek Holdings reported no remaining BioMarin Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Temasek Holdings sold 2,372,712 BioMarin Pharmaceuticals shares in Q2 2020, an estimated $200M.
Temasek Holdings first reported a position in BioMarin Pharmaceuticals in Q1 2014 and held it in 25 quarters.
Temasek Holdings's BioMarin Pharmaceuticals position peaked at $364M in Q4 2015.
527 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2020.

Based on Temasek Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.